Blog
>
News
>
Navigating Cancer Care and Cannabis Use: Transforming Workplace Support

Navigating Cancer Care and Cannabis Use: Transforming Workplace Support

As employers continue to navigate the evolving dynamics of employee cannabis use, Human Resource Executive spoke with Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology...

Learn More About EO's Products

Every EO product is clinician-designed and precisely dosed. Inhalers, gummies, tablets, tinctures, topicals, and beverage shots. They ship straight to your door, no dispensary needed.

Responsibly Made & Tested

  • ✓ 100% organic hemp, no synthetics
  • ✓ Produced at GMP-certified facilities
  • ✓ 3rd-party tested for accuracy/safety

Federally Legal

  • ✓ <0.3% hemp-derived THC
  • ✓ Farm Bill compliant
  • ✓ Ships to your door like any package

Expert Guidance Included

  • ✓ Ensure optimal dosing
  • ✓ Minimize side effects
  • ✓ Use safely and wisely
Explore

As employers continue to navigate the evolving dynamics of employee cannabis use, Human Resource Executive spoke with Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology, and the Program Director of Cannabis Medicine for the Science and Business Master’s Program. In the article When it comes to cancer care, employers need more guidance on cannabis use Dr. Brooke Worster, M.D. provides an expert medical perspective on critical illness and survivorship, the medical use of cannabis, how to improve guidance around the management of cancer-related side effects, and helps employers to better understand workplace support and safe return-to-work options.

Cancer still casts a significant shadow with a 40% chance of a cancer diagnosis in a lifetime. Through improved detection and medical advances, survival rates are on the upswing and there is a growing number of individuals living with the aftermath of cancer and its treatments.

As many survivors strive to rejoin the workforce while they manage the ongoing challenges that accompany cancer's aftermath, cannabis has provided health benefits for cancer patients to manage chronic pain, nausea, sleep disturbances, and anxiety – both during treatment and survivorship. 40% of patients with cancer will use cannabis at some point along their cancer trajectory for treatment-related side effects. Today, people are using cannabis unsafely and ineffectively due to a lack of clinical guidance. Employees, particularly those from less privileged backgrounds, face a mortality rate 14% to 25% higher than their wealthier counterparts. 

The quest for safe, alternative therapies for those grappling with the long-term aftermath of cancer and eager to resume their professional lives gives employers a vital role as a catalyst for change in the lives of battling employees. Guided cannabis usage emerges as a powerful tool to level the playing field, mitigate risks, and improve overall well-being. 

Learn how HR leaders can proactively create supportive workplace environments. 

Read the full article here

These statements have not been evaluated by the Food and Drug Administration. This page is not intended to diagnose, mitigate, treat, cure, or prevent any disease.

Free Care Plans? Of Course.

Everyone deserves personalized, clinically responsible cannabis guidance. Tell us about your symptoms, get a plan from our clinician-led team, and message them anytime. Free, with up to 20% off the products in your plan.

Get a Free Care Plan
More
News
News

ASCO Annual Meeting 2026: Iterative Cannabis Care Plans

At the 2026 ASCO Annual Meeting, cannabinoid-based symptom management was recognized for its critical role in improving patient outcomes.

Read More
Read More
News

Cannabis Rescheduling: A Turning Point for Symptom Management in Healthcare

A major policy shift is reshaping how providers and payers approach symptom management. Here’s what cannabis rescheduling means for clinical care, reimbursement, and patient outcomes.

Read More
Read More
News

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.

Read More
Read More